News & Events News Discover the latest breakthroughs, stories, and updates from Oncode Institute’s mission to outsmart cancer. Search Category Categorypress newsResearch news New research reveals that the actionable metastatic cancer genome is remarkably stable 9 Aug 2021 Absence of stem cells in pancreas changes view on pancreatic cancer 5 Aug 2021 Antibodies with a mission: what the Utrecht Monoclonal Antibody Facility (UMab) can do for you 27 Jul 2021 Oncode collaboration results in a new mathematical method that can predict cancer survival based on genetic changes 20 Jul 2021 Oncode Investigators Hugo Snippert and Jarno Drost receive NWO-Vidi grant 14 Jul 2021 Oncode and NKI spinout a new company targeting senescence in oncology, led by Rene Bernards 12 Jul 2021 Unraveling the genetic evolution of individual tumor cells 1 Jul 2021 Oncode Investigator Jarno Drost and his team part of joint research that uncovers the cellular signatures of kidney tumors 30 Jun 2021 Fully online, always together: looking back at the third edition of Oncode’s CGC Annual Scientific Meeting 29 Jun 2021 Research/Industry collaboration on potential anti-cancer treatment published in eLife 22 Jun 2021 Dear world: meet ELOF1 – the newly discovered core factor in the TC-NER pathway 10 Jun 2021 Oncode Investigators Karin de Visser and Wim Vermeulen elected to the prestigious EMBO membership 8 Jun 2021 The development of novel technology for improved detection of clinically relevant chromosomal rearrangements in tumors 7 Jun 2021 2020: Accelerating to Full Speed 2 Jun 2021 Researchers find new method to reduce the risk of developing colon cancer 1 Jun 2021 New CPoC grant awarded: GLOW - GLioblastoma targeted treatment Option maximisation by Wgs 27 May 2021 Pagination Previous page ‹ … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Next page ›
Antibodies with a mission: what the Utrecht Monoclonal Antibody Facility (UMab) can do for you 27 Jul 2021
Oncode collaboration results in a new mathematical method that can predict cancer survival based on genetic changes 20 Jul 2021
Oncode and NKI spinout a new company targeting senescence in oncology, led by Rene Bernards 12 Jul 2021
Oncode Investigator Jarno Drost and his team part of joint research that uncovers the cellular signatures of kidney tumors 30 Jun 2021
Fully online, always together: looking back at the third edition of Oncode’s CGC Annual Scientific Meeting 29 Jun 2021
Oncode Investigators Karin de Visser and Wim Vermeulen elected to the prestigious EMBO membership 8 Jun 2021
The development of novel technology for improved detection of clinically relevant chromosomal rearrangements in tumors 7 Jun 2021
New CPoC grant awarded: GLOW - GLioblastoma targeted treatment Option maximisation by Wgs 27 May 2021
